These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 4895429)
1. Effects of chlorambucil (NSC-3088) in 374 patients with advanced cancer. Eastern Clinical Drug Evualuation Program. Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA Cancer Chemother Rep; 1968 Oct; 52(6):661-6. PubMed ID: 4895429 [No Abstract] [Full Text] [Related]
2. Effects of mitomycin c (NSC-26980) in 346 patients with advanced cancer. Eastern Clinical Drug Evaluation Program. Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA Cancer Chemother Rep; 1968 Oct; 52(6):675-84. PubMed ID: 5753587 [No Abstract] [Full Text] [Related]
3. [Taxotere in various solid tumors]. Orel NF Vopr Onkol; 1998; 44(5):639-44. PubMed ID: 9925501 [No Abstract] [Full Text] [Related]
4. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program. Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA Cancer Chemother Rep; 1968 Oct; 52(6):667-73. PubMed ID: 4895430 [No Abstract] [Full Text] [Related]
5. Methotrexate (NSC-740) and bleomycin (NSC-125066) in the treatment of advanced epidermoid carcinoma of the uterine cervix. de Palo GM; Bajetta E; Luciani L; Musumeci R; Di Re F; Bonadonna G Cancer Chemother Rep; 1973; 57(4):429-35. PubMed ID: 4128423 [No Abstract] [Full Text] [Related]
6. Acute leukemia following chlorambucil therapy of advanced ovarian and fallopian tube carcinoma. Morrison J; Yon JL Gynecol Oncol; 1978 Feb; 6(1):115-20. PubMed ID: 620948 [No Abstract] [Full Text] [Related]
8. [A trial of clinical use of the antibiotic chrysomallin]. Raevskiĭ IG Antibiotiki; 1967 Mar; 12(3):255-8. PubMed ID: 4174259 [No Abstract] [Full Text] [Related]
9. The current management of malignancy -- VI other solid tumors. Panettiere FJ Alaska Med; 1977 Mar; 19(2):19-25. PubMed ID: 326087 [No Abstract] [Full Text] [Related]
10. Effects of 5-fluorouracil (NSC-19893) in 389 patients with cancer. Eastern Clinical Drug Evaluation Program. Moore GE; Bross ID; Ausmans R; Nadler S; Jones R; Slack N; Rimm AA Cancer Chemother Rep; 1968 Oct; 52(6):641-53. PubMed ID: 4895427 [No Abstract] [Full Text] [Related]
11. Palliation chemotherapy of pelvic carcinoma by systemic, perfusion, and infusion modalities. Boutselis JG; Ullery JC; Pace W Ohio State Med J; 1971 Aug; 67(8):721-5. PubMed ID: 4105456 [No Abstract] [Full Text] [Related]
12. Further experience with hexamethylmelamine (NSC-13875) in the treatment of carcinoma of the cervix. Stolinsky DC; Bateman JR Cancer Chemother Rep; 1973; 57(4):497-9. PubMed ID: 4586957 [No Abstract] [Full Text] [Related]
13. Clinical experience gained in the treatment of advanced genital cancer by the application of the MBBA preparation. Dvorák O; Semonský M Neoplasma; 1967; 14(2):135-44. PubMed ID: 4382232 [No Abstract] [Full Text] [Related]
14. Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma. Johnsson JE; Tropé C; Mattsson W; Grundsell H; Aspegren K; Könyves I Cancer Treat Rep; 1979 Mar; 63(3):421-4. PubMed ID: 371798 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of combined radiation-chlorambucil treatment of ovarian carcinomatosis. Miller SP; Brenner S; Horton J; Stolbach L; Shnider BI; Pocock S Cancer; 1975 Nov; 36(5):1625-30. PubMed ID: 811350 [TBL] [Abstract][Full Text] [Related]
17. Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893). Tucker WG; Talley RW; Lane M; Bonnet JD Cancer Chemother Rep; 1975; 59(2 Pt 1):425-7. PubMed ID: 1097101 [No Abstract] [Full Text] [Related]
18. [Favorable course in carcinoma patients due to additional phenothiazine therapy]. Eicke WJ Med Klin; 1973 Jul; 68(30):1015-8. PubMed ID: 4725489 [No Abstract] [Full Text] [Related]
19. Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells. Maiti AK Pharmacogenomics J; 2010 Apr; 10(2):94-104. PubMed ID: 19918261 [TBL] [Abstract][Full Text] [Related]
20. [Report on the management of advanced ovarian cancer using Endoxan (Asta) and cyclophosphamide preparations]. Dvorák O; Spirová M Zentralbl Gynakol; 1967 Jul; 89(26):940-5. PubMed ID: 5587033 [No Abstract] [Full Text] [Related] [Next] [New Search]